Cardiotoxicity of Non cardiovascular Drugs 1st Edition by Giorgio Minotti – Ebook PDF Instant Download/Delivery. 9780470660386 ,0470660384
Full download Cardiotoxicity of Non cardiovascular Drugs 1st Edition after payment
Product details:
ISBN 10: 0470660384
ISBN 13: 9780470660386
Author: Giorgio Minotti
Cardiotoxicity of Non cardiovascular Drugs 1st Edition Table of contents:
Chapter 1: Introduction to Drug-Induced Cardiotoxicity
- Definition and Importance of Cardiotoxicity
- Mechanisms of Cardiotoxicity
- Epidemiology and Risk Factors for Drug-Induced Cardiotoxicity
- Overview of Drugs with Known Cardiotoxic Effects
Chapter 2: Mechanisms of Cardiotoxicity
- Direct vs. Indirect Mechanisms of Cardiotoxicity
- Cellular and Molecular Mechanisms: Oxidative Stress, Inflammation, and Calcium Dysregulation
- Mitochondrial Dysfunction and Cardiotoxicity
- Genetic and Environmental Factors in Drug-Induced Cardiovascular Injury
Chapter 3: Chemotherapeutic Agents and Cardiotoxicity
- Cardiotoxic Effects of Chemotherapy: An Overview
- Mechanisms of Chemotherapy-Induced Cardiotoxicity
- Common Chemotherapeutic Agents: Anthracyclines, Trastuzumab, and Others
- Early Detection and Monitoring of Cardiotoxicity in Cancer Patients
- Management Strategies for Chemotherapy-Induced Cardiotoxicity
Chapter 4: Antimicrobials and Cardiotoxicity
- Cardiotoxic Effects of Antibiotics and Antifungals
- Mechanisms of Antimicrobial-Induced Cardiotoxicity
- Specific Drugs: Quinidine, Amphotericin B, and Others
- Monitoring and Preventative Strategies for Cardiotoxicity in Antimicrobial Therapy
Chapter 5: Immunosuppressive Drugs and Cardiotoxicity
- Cardiotoxic Effects of Immunosuppressive Agents
- Drugs Involved: Cyclosporine, Tacrolimus, and Others
- Mechanisms of Immunosuppressant-Induced Cardiotoxicity
- Clinical Presentation and Monitoring of Cardiotoxicity in Immunosuppressive Therapy
Chapter 6: Antidepressants and Cardiotoxicity
- Cardiovascular Effects of Antidepressants: SSRIs, SNRIs, and Tricyclic Antidepressants
- Mechanisms of Cardiotoxicity: QT Prolongation and Arrhythmias
- Antidepressants and Heart Failure: Risk Factors and Management
- Clinical Monitoring and Management Strategies
Chapter 7: Antipsychotics and Cardiotoxicity
- Cardiovascular Risks of Antipsychotic Medications
- Mechanisms: QT Interval Prolongation and Arrhythmias
- Specific Antipsychotics and Their Cardiovascular Effects
- Monitoring, Prevention, and Treatment of Antipsychotic-Induced Cardiotoxicity
Chapter 8: Anti-inflammatory Drugs and Cardiotoxicity
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Cardiotoxicity
- Mechanisms of NSAID-Induced Cardiovascular Injury
- Corticosteroids and Their Effects on the Heart
- Strategies for Minimizing the Risk of Cardiotoxicity in Anti-inflammatory Drug Therapy
Chapter 9: Anti-epileptic Drugs and Cardiotoxicity
- Cardiovascular Effects of Antiepileptic Medications
- Mechanisms and Risk Factors in Anti-epileptic Drug-Induced Cardiotoxicity
- Specific Anti-epileptic Drugs: Phenytoin, Valproate, and Others
- Clinical Management and Monitoring of Cardiotoxicity in Epilepsy Treatment
Chapter 10: Cardiovascular Risk of Hormonal Therapies
- Hormonal Medications and Their Impact on Cardiovascular Health
- Oral Contraceptives, Hormone Replacement Therapy, and Pregnancy-Related Drugs
- Mechanisms and Risk Factors for Hormonal Therapy-Induced Cardiotoxicity
- Clinical Recommendations and Monitoring Strategies for Hormonal Therapy
Chapter 11: Cardiotoxicity of Illicit Drugs
- The Cardiovascular Risks of Illicit Drug Use
- Drugs Involved: Cocaine, Methamphetamine, and Other Stimulants
- Mechanisms of Cardiotoxicity in Drug Abuse
- Prevention, Monitoring, and Management of Cardiotoxicity in Substance Abuse
Chapter 12: Diagnostic Approaches to Drug-Induced Cardiotoxicity
- Clinical Diagnosis of Drug-Induced Cardiotoxicity
- Role of Biomarkers in Identifying Cardiotoxicity
- Imaging Techniques: Echocardiography, MRI, and Others
- Electrocardiographic Changes in Drug-Induced Cardiotoxicity
- Advanced Diagnostic Tools and Approaches
Chapter 13: Management and Prevention of Drug-Induced Cardiotoxicity
- General Principles of Management for Cardiotoxicity
- Preventive Strategies in High-Risk Populations
- Therapeutic Approaches to Treat Drug-Induced Cardiovascular Injury
- Role of Cardiology and Pharmacology in Managing Cardiotoxicity
- Case Studies and Clinical Management Scenarios
Chapter 14: Future Perspectives in Cardiotoxicity Research
- Advancements in the Understanding of Drug-Induced Cardiac Injury
- Novel Therapeutic Approaches and Potential Interventions
- The Role of Pharmacogenomics in Preventing Cardiotoxicity
- Emerging Drugs and Their Cardiotoxic Risks
- Future Directions in Cardiotoxicity Screening and Management
People also search for Cardiotoxicity of Non cardiovascular Drugs 1st Edition:
cardiotoxicity of cyclophosphamide
cardiotoxicity of doxorubicin
cardiotoxicity of carboplatin
is cardiotoxicity reversible